Literature DB >> 12207147

Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy.

Guido Rodriguez1, Paolo Vitali, Caterina De Leo, Fabrizio De Carli, Nicola Girtler, Flavio Nobili.   

Abstract

Twenty patients affected with probable mild-to-moderate Alzheimer's disease (AD; NINCDS-ADRDA criteria; 14 women and 6 men, mean age 75.2 +/- 7.1 years) who regularly received an oral acetylcholinesterase inhibitor (AChEI; donepezil 5 mg/day; Dz group) were compared with a control group of 11 AD patients (6 women and 5 men, mean age 73.5 +/- 6.0 years) diagnosed and followed up in the pre-AChEIs era (C group). At basal evaluation (t(0)), the 2 groups were comparable for age, education, and severity of disease (Global Deterioration Scale). All patients underwent quantitative EEG (qEEG, average reference, 10-20 International System), and were reexamined about 1 year later (t(1); i.e., after 12.3 +/- 3.6 months the Dz group, and after 13.7 +/- 3.9 months the C group). Log-transformed values of two qEEG bands, i.e. 2-6 and 6.5-12 Hz, were averaged between adjacent channels (frontal F3 and F7, F4 and F8; parietotemporal P3 and T7, P4 and T8) to obtain a qEEG ratio (6.5-12/2-6 Hz.) from one frontal and one temporoparietal region in each hemisphere. Neuropsychological impairment was summarized by the Mini-Mental Status Examination (MMSE). At t(0), both the MMSE score and the qEEG ratio values were somewhat higher in the C than in the Dz group, although nonsignificantly. Between t(0) and t(1), the MMSE score decreased significantly (p < 0.01) more in the C group (-4.36 +/- 2.25) than in the Dz group (-1.45 +/- 2.16), as did the qEEG ratio in the right frontal region (p < 0.01), whereas in the left frontal region the significance level was not reached (p = 0.02). Between t(0) and t(1), the qEEG ratio difference in both frontal regions and in the right temporoparietal region significantly correlated with the MMSE difference (p < 0.01), but neither with time between examinations nor with the difference on the Visual Search Test score. Long-term treatment with Dz led to a lesser deterioration of qEEG, paralleling a milder neuropsychological decline. The effect was significant in frontal regions, possibly because they are relatively spared during the mild-to-moderate phases of the disease. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207147     DOI: 10.1159/000063576

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  17 in total

1.  Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers.

Authors:  G Dunbar; P H Boeijinga; A Demazières; C Cisterni; R Kuchibhatla; K Wesnes; R Luthringer
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 2.  Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?

Authors:  Ben Seltzer
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease.

Authors:  Claudio Babiloni; Claudio Del Percio; Marina Boccardi; Roberta Lizio; Susanna Lopez; Filippo Carducci; Nicola Marzano; Andrea Soricelli; Raffaele Ferri; Antonio Ivano Triggiani; Annapaola Prestia; Serenella Salinari; Paul E Rasser; Erol Basar; Francesco Famà; Flavio Nobili; Görsev Yener; Derya Durusu Emek-Savaş; Loreto Gesualdo; Ciro Mundi; Paul M Thompson; Paolo M Rossini; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2014-09-21       Impact factor: 4.673

Review 4.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment.

Authors:  Claudio Babiloni; Michela Pievani; Fabrizio Vecchio; Cristina Geroldi; Fabrizio Eusebi; Claudia Fracassi; Evan Fletcher; Charles De Carli; Marina Boccardi; Paolo Maria Rossini; Giovanni B Frisoni
Journal:  Hum Brain Mapp       Date:  2009-05       Impact factor: 5.038

6.  White matter vascular lesions are related to parietal-to-frontal coupling of EEG rhythms in mild cognitive impairment.

Authors:  Claudio Babiloni; Giovanni B Frisoni; Michela Pievani; Fabrizio Vecchio; Francesco Infarinato; Cristina Geroldi; Serenella Salinari; Raffaele Ferri; Claudia Fracassi; Fabrizio Eusebi; Paolo M Rossini
Journal:  Hum Brain Mapp       Date:  2008-12       Impact factor: 5.038

7.  Electroencephalographic rhythms in Alzheimer's disease.

Authors:  Roberta Lizio; Fabrizio Vecchio; Giovanni B Frisoni; Raffaele Ferri; Guido Rodriguez; Claudio Babiloni
Journal:  Int J Alzheimers Dis       Date:  2011-05-12

8.  Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkers.

Authors:  Joshua H Balsters; Redmond G O'Connell; Mary P Martin; Alessandra Galli; Sarah M Cassidy; Sophia M Kilcullen; Sonja Delmonte; Sabina Brennan; Jim F Meaney; Andrew J Fagan; Arun L W Bokde; Neil Upton; Robert Lai; Marc Laruelle; Brian Lawlor; Ian H Robertson
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

9.  Donepezil in Alzheimer's disease: an evidence-based review of its impact on clinical and economic outcomes.

Authors:  Joanne Knowles
Journal:  Core Evid       Date:  2006-03-31

10.  Increased EEG gamma band activity in Alzheimer's disease and mild cognitive impairment.

Authors:  J A van Deursen; E F P M Vuurman; F R J Verhey; V H J M van Kranen-Mastenbroek; W J Riedel
Journal:  J Neural Transm (Vienna)       Date:  2008-07-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.